TABLE 2

Mixed-effects single variable logistic regression models on the association of neutrophil-to-lymphocyte ratio and blood eosinophils to risk of acute exacerbation of COPD the following year

OR (95% CI)
NLR, continuous variable
 Entire study population1.48 (1.21–1.81)
 No AECOPD previous year1.23 (0.88–1.72)
 ≥1 AECOPD previous year1.64 (1.14–2.36)
NLR ≥3.00 versus <3.00
 Entire study population1.61 (0.91–2.84)
 No AECOPD previous year0.89 (0.36–2.22)
 ≥1 AECOPD previous year2.88 (1.00–8.25)
B-Eos, continuous variable#
 Entire study population1.02 (0.86–1.19)
 No AECOPD previous year1.10 (0.87–1.37)
 ≥1 AECOPD previous year0.96 (0.72–1.28)
B-Eos ≥300 versus <300 cells·µL−1
 Entire study population1.47 (0.83–2.63)
 No AECOPD previous year2.10 (0.84–5.15)
 ≥1 AECOPD previous year1.15 (0.40–3.28)

Models were calculated for the entire study population, and for observations where the subjects had and had not had an acute exacerbation the previous year, respectively. Each row represents a separate model. NLR: blood neutrophil-to-lymphocyte ratio; AECOPD: acute exacerbation of COPD; B-Eos: blood eosinophils. #: per 100 cells·µL−1 increase.